Patient Name : Mr Mr Dipanku Goswami

DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM

Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Whole blood EDTA Report Date : Nov 05, 2023, 02:03 PM
Barcode No : HX528844 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

HEMATOLOGY REPORT
Whealth Full Body Checkup With Vitamin Screening New
HbA1C (Glycosylated Haemoglobin)
GLYCOSYLATED HEMOGLOBIN (HbA1c) 6.2 % < 5.7
Method : HPLC
ESTIMATED AVERAGE GLUCOSE * 131.24

Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5

Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 %
may not be appropriate.

Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as
compared to blood and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 1 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Whole blood EDTA Report Date : Nov 05, 2023, 02:03 PM
Barcode No : HX528844 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 2 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : FLUORIDE F Report Date : Nov 05, 2023, 02:12 PM
Barcode No : ZA304563 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
Glucose Fasting (BSF)
GLUCOSE FASTING 92.5 mg/dL 70 - 100
Method : Hexokinase

Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126

Reference : American Diabetes Association

Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.

Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 3 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Serum Report Date : Nov 05, 2023, 03:05 PM
Barcode No : ZA304562 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
Liver Function Test (LFT)
BILIRUBIN TOTAL 0.5 mg/dL 0.2 - 1.2
Method : Photometric
BILIRUBIN DIRECT * 0.2 mg/dL 0.0 - 0.5
Method : Diazo Reaction
BILIRUBIN INDIRECT * 0.3 mg/dL 0.1 - 1.0
Method : Calculation (T Bil - D Bil)
SGOT/AST 18.3 U/L 5 - 34
Method : IFCC without P5P
SGPT/ALT 21.8 U/L 0 to 55
Method : IFCC without P5P
SGOT/SGPT Ratio * 0.84 - -
ALKALINE PHOSPHATASE 56 U/L 40 - 150
Method : p-nitrophenyl Phosphate, AMP buffer
TOTAL PROTEIN 6.9 g/dL 6.4 - 8.3
Method : Biuret
ALBUMIN 4.3 gm/dL 3.8 - 5.0
Method : BCG
GLOBULIN * 2.6 g/dL 2.3 - 3.5
Method : Calculation (T.P - Albumin)
ALBUMIN : GLOBULIN RATIO * 1.65 - 1.0 - 2.1
Method : Calculation (Albumin/Globulin)
GAMMA GLUTAMYL TRANSFERASE (GGT) * 18.7 U/L 12 - 64
Method : ENZYMATIC

Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood clotting proteins, and
performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical reactions. When liver cells are damaged or
destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood tests Liver tests check the blood for two main liver enzymes. Aspartate
aminotransferase (AST),SGOT: The AST enzyme is also found in muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is
almost exclusively found in the liver. If ALT and AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase
and GGT: Another of the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is
eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise: Alkaline phosphatase Gamma-utamyl
transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is by far the most commonly tested of the three. If
alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile flow problems can be due to a problem in the liver, the gallbladder, or
the tubes connecting them. Proteins are important building blocks of all cells and tissues. Proteins are necessary for your body's growth, development, and health. Blood
contains two classes of protein, albumin and globulin. Albumin proteins keep fluid from leaking out of blood vessels. Globulin proteins play an important role in your
immune system. Low total protein may indicate: 1.bleeding 2.liver disorder 3.malnutrition 4.agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen
in dehydration due to inadequate water intake or to excessive water loss (eg, severe vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased
production of proteins Low albumin levels may be caused by: 1.A poor diet (malnutrition). 2.Kidney disease. 3.Liver disease. High albumin levels may be caused by:
Severe dehydration.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 4 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Serum Report Date : Nov 05, 2023, 03:05 PM
Barcode No : ZA304562 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
Kidney Function Test (KFT)
BLOOD UREA 20.6 mg/dL 19 - 44.1
Method : Modified Jaffe
CREATININE 0.9 mg/dL 0.72 - 1.25
Method : Modified Jaffe
BUN * 9.63 mg/dL 8.9 - 20.6
Method : Urease
BUN/CREATININE RATIO * 10.7
UREA / CREATININE RATIO * 22.89
URIC ACID 7.2 mg/dL 3.5 - 7.2
Method : Uricase
CALCIUM Serum 8.9 mg/dL 8.4 - 10.2
Method : O-Cresolphthalein Complex
PHOSPHORUS 3.3 mg/dL 2.3 - 4.7
Method : Colorimetric - Phosphomolybdate Formation
SODIUM 138.3 mmol/L 136 - 145
Method : Direct ISE
POTASSIUM 3.8 mmol/L 3.5 - 5.1
Method : Direct ISE
CHLORIDE 98 mmol/L 98 - 107
Method : Direct ISE

Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual
(chronic) declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may
indicate a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful
urination,swelling in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring
simultaneously, these symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes
(sodium,potassium,and chloride) are present in the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells
and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or parathyroid disease. The test may also be done to monitor progress
and treatment of these diseases.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 5 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Serum Report Date : Nov 05, 2023, 03:05 PM
Barcode No : ZA304562 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
Lipid Profile
TOTAL CHOLESTEROL 189 mg/dL Desirable : <200
Method : Enzymatic - Cholesterol Oxidase Borderline : 200-239
High : >240
TRIGLYCERIDES 281 mg/dL Normal : <150
Method : Colorimetric - Lip/Glycerol Kinase Borderline : 150-199
High : 200-499
Very high : >500
HDL CHOLESTEROL 50.2 mg/dL >40
Method : Accelerator Selective Detergent
NON HDL CHOLESTEROL * 138.8 mg/dL <130
Method : Calculated
LDL CHOLESTEROL * 82.6 mg/dL Optimal <100
Method : Calculated Near optimal/above optimal
100-129 Borderline high
130-159
High 160-189
Very high >190
V.L.D.L CHOLESTEROL * 56.2 mg/dL < 30
Method : Calculated
CHOL/HDL Ratio * 3.76 - 3.5 - 5.0
Method : Calculated
HDL/ LDL RATIO * 0.61 - Desirable : 0.5 - 3.0
Method : Calculated
Borderline : 3.1 - 6.0

High : > 6.0

LDL/HDL Ratio * 1.65 -
Method : Calculated

Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.

National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159

Borderline High 200-239 150-199 130-159 160 - 189

High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 6 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Serum Report Date : Nov 05, 2023, 03:05 PM
Barcode No : ZA304562 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.

Risk Category A. CAD with > 1 feature of high risk group

B. CAD with >1 feature of very high risk group of recurrent ACS (within 1 year) despite LDL-C <or = 50 mg/dl
Extreme risk group
or poly vascular disease
1.Established ASCVD 2.Diabetes with 2 major risk factors of evidence of end organ
Very High Risk
damage 3. Familial Homozygous Hypercholesterolemia
1. Three major ASCVD risk factors 2. Diabetes with 1 major risk factor or no evidence
of end organ damage 3. CHD stage 3B or 4. 4 LDL >190 mg/dl 5. Extreme of a single
High Risk
risk factor 6. Coronary Artery Calcium - CAC > 300 AU 7. Lipoprotein a >/= 50 mg/dl
8. Non stenotic carotid plaque
Moderate Risk 2 major ASCVD risk factors
Low Risk 0-1 major ASCVD risk factors

Major ASCVD (Atherosclerotic cardiovascular disease) Risk Factors

1. Age >/=45 years in Males &

3. Current Cigarette smoking or tobacco use
>/= 55 years in Females
2. Family history of premature
4. High blood pressure
ASCVD
5. Low HDL

Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.

Risk Group Treatment Goals Consider Drug Therapy

LDL-C (mg/dl) Non-HDL (mg/dl) LDL-C (mg/dl) Non-HDL (mg/dl)
Extreme Risk Group Category A <50 (Optional goal <OR = 30) <80 (Optional goal <OR = 60) >OR = 50 >OR = 80
Extreme Risk Group Category B >OR = 30 >OR = 60 > 30 > 60
Very High Risk <50 <80 >OR = 50 >OR = 80
High Risk <70 <100 >OR = 70 >OR = 100
Moderate Risk <100 <130 >OR = 100 >OR = 130
Low Risk <100 <130 >OR = 130* >OR = 160

* After an adequate non-pharmacological intervention for at least 3 months.

References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 7 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Serum Report Date : Nov 05, 2023, 03:05 PM
Barcode No : ZA304562 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
Lipase
Lipase 30.7 U/L <67
Method : Spectrophotometry

Interpretation:
Pancreas is the major and primary source of serum lipase though lipases are also present in liver, stomach, intestine, WBC, fat cells and milk. In acute pancreatitis,
serum lipase becomes elevated at the same time as amylase and remains high for 7-10 days. Increased
lipase activity rarely lasts longer than 14 days. Prolonged increase suggests poor prognosis or presence of a cyst. The combined use of serum lipase and serum
amylase is effective in ruling out acute pancreatitis.

Increased levels
Acute & Chronic pancreatitis
Obstruction of pancreatic duct
Non pancreatic conditions like renal diseases, acute cholecystitis, intestinal obstruction, duodenal ulcer, alcoholism, diabetic ketoacidosis and following endoscopic
retrograde cholangiopancreatography

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 8 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Serum Report Date : Nov 05, 2023, 03:50 PM
Barcode No : ZA304562 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
Amylase
Amylase 63 U/L 25 - 125
Method : Serum,. 2-chloro-p-nitrophenyl-a-D-maltotrioside

Interpretation:
1. Amylase levels are significantly increased in patients with acute pancreatitis, pancreatic duct obstruction, carcinoma pancreas, ovaries, or lungs, cholecystitis,
macroamylasemia, renal disease, pancreatic pseudocyst, procedures like Endoscopic retrograde cholangiopancreatography and acute alcohol poisoning.
2. In acute pancreatitis, elevated amylase levels usually parallel lipase concentrations, although lipase levels may take a bit longer to rise than blood amylase levels
and will remain elevated longer.
3. Amylase levels are raised in aspirin, diuretics, oral contraceptives, corticosteroids, indomethacin, ethyl alcohol and opiate intake

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
High Sensitivity C-Reactive Protein (Hs-CRP)
HIGHLY SENSITIVE C-REACTIVE PROTEIN (hs- 1.2 mg/L Low < 1.00 mg/L
CRP)
Method : Particle enhanced immunoturbidimetric assay. Average 1.0-3.0 mg/L

High > 3.0 mg/L

Interpretation:
Note: To assess vascular risk, it is recommended to test hsCRP levels 2 or more weeks apart and calculate the average

Comments
High sensitivity C Reactive Protein (hsCRP) significantly improves cardiovascular risk assessment as it is a strongest predictor of future
coronary events. It reveals the risk of future Myocardial infarction and Stroke among healthy men and women, independent of traditional risk
factors. It identifies patients at risk of first Myocardial infarction even with low to moderate lipid levels. The risk of recurrent cardiovascular events
also correlates well with hsCRP levels. It is a powerful independent risk determinant in the prediction of incident Diabetes.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 9 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Serum Report Date : Nov 05, 2023, 03:05 PM
Barcode No : ZA304562 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
Vitamin B12 / Cyanocobalamin
Vitamin - B12 285.2 pg/mL 187 - 883
Method : ECLIA

Interpretation:
Low Values are a sign of a vitamin B12 deficiency. People with this deficiency are likely to have or develop symptoms.
Causes of vitamin B12 deficiency include:Not enough vitamin B12 in diet (rare except with a strict vegetarian diet), Diseases that cause
malabsorption (for example, celiac disease and Crohn's disease), Lack of intrinsic factor, Above normal heat production (for example, with
hyperthyroidism), Pregnancy. Increased vitamin B12 levels are uncommon. Usually excess vitamin B12 is removed in the urine. Conditions that can
increase B12 levels include: Liver disease (such as cirrhosis or hepatitis), Myeloproliferative disorders (for example, polycythemia vera and chronic
myelocytic leukemia).
Vitamin B12: Low Levels can cause malabsorption, Lack of intrinsic factor, Above normal heat production (for example, with hyperthyroidism),
Pregnancy.High Level Liver disease, Myeloproliferative disorders (for example, polycythemia vera and chronic myelocytic leukemia).
1. Out of 140 healthy indian population, 91% of Vitamin B 12 concentrations was at lower level: 59.00 pg/ml and upper level: 700.00 pg/ml

"Patients on Biotin supplement may have interference in some immunoassays. Ref: Arch Pathol Lab Med—Vol 141, November 2017. With
individuals taking high dose Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is recommended."

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 10 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Serum Report Date : Nov 05, 2023, 03:05 PM
Barcode No : ZA304562 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
Vitamin D 25 Hydroxy
Vitamin D 25 - Hydroxy 3.57 ng/mL Deficiency : <30 ng/mL
Method : ECLIA

Interpretation:
25-Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with Osteoporosis /
Secondary Hyperparathyroidism while severe deficiency causes Rickets in children and Osteomalacia in adults. Prevalence of Vitamin D deficiency
is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D deficiency and Hypervitaminosis D. It is also used
for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring Vitamin D replacement therapy.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 11 of 12
 Patient Name : Mr Mr Dipanku Goswami
DOB/Age/Gender : 40 Y/Male Bill Date : Nov 04, 2023, 07:28 PM
Patient ID / UHID : 6101136/RCL5219293 Sample Collected : Nov 05, 2023, 08:28 AM
Referred By : Dr. Sample Received : Nov 05, 2023, 01:20 PM
Sample Type : Serum Report Date : Nov 05, 2023, 03:05 PM
Barcode No : ZA304562 Report Status : Final Report

Test Description Value(s) Unit(s) Reference Range

BIOCHEMISTRY REPORT
Whealth Full Body Checkup With Vitamin Screening New
TSH 3rd Generation
THYROID STIMULATING HORMONE (Ultrasensitive) 1.8 mIU/L 0.35 - 4.94
Method : ECLIA

Interpretation:
Pregnancy Reference ranges TSH
1 st Trimester 0.1 - 2.5
2 ed Trimester 0.2 - 3.0
3 rd Trimester 0.3 - 3.0
TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a minimum between 6-10 pm . The variation is of
the order of 50% . hence time of the day has influence on the measured serum TSH concentrations.

Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH directly
affects thyroid function, malfunction of the pituitary or the hypo - thalamus influences the thyroid gland activity. Disease in any portion of the
thyroid-pitutary-hypothala- mus system may influence the levels of T3 and T4 in the blood. In primary hypothyroidism, TSH levels are
significantly elevated, while in secondary and tertiary hypothyroidism, TSH levels may be low. In addition, in the Euthyroid Sick Syndrome,
multiple alterations in serum thyroid function test findings have been recognized in patients with a wide variety of non-thyroidal illnesses (NTI)
without evidence of preexisting thyroid or hypothalami c-pitutary diseases.

Thyroid Binding Globulin (TBG) concentrations remain relatively constant in healthy individuals. However, pregnancy, excess estrogen,
androgen, antibiotics, steroids and glucocorticoids are known to alter TBG levels and may cause false thyroid values for Total T3 and T4 tests.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- WHEALTH NOIDA, WHEALTH NOIDA

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., Second Floor, Dag No.238, 243, Patta no.723,1166, Mauza, Beltola - Khanapara Rd,
Odalbakra, Guwahati, Assam 781034

Page 12 of 12
 Terms and Conditions of Reporting

1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.

2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.

3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.

4. This report shall not be deemed valid or admissible for any medico-legal purposes.

5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.